This live activity will cover early detection and intervention in cancer.

The COVID-19 FRONTLINE Grand Rounds series provides a comprehensive and up-to-date perspective on the ever-changing management of patients with COVID-19. Each Grand Rounds session features in-depth case studies to encourage retention of the lessons and provide new perspectives on the management of patients during the COVID-19 pandemic. This program will focus on optimizing outcomes for hospitalized and nonhospitalized patients with COVID-19 through the use of novel agents authorized for emergency use.

This live activity will cover early detection and intervention in cancer.

This live virtual activity will cover the care and treatment of patients with moderate to severe atopic dermatitis.

This live, case-based activity will explore the role of screening and surveillance for patients with esophageal cancer (EC) and review clinical trial data on the efficacy and safety of immune checkpoint inhibitors as adjuvant treatment and across lines of therapy.

This live, case-based activity will explore the role of screening and surveillance for patients with esophageal cancer (EC) and review clinical trial data on the efficacy and safety of immune checkpoint inhibitors as adjuvant treatment and across lines of therapy.

This activity will cover the treatment and management of patients locally-advanced or metastatic urothelial carcinoma.

This live activity will cover early detection and intervention in cancer.

The COVID-19 FRONTLINE Grand Rounds series provides a comprehensive and up-to-date perspective on the ever-changing management of patients with COVID-19. Each Grand Rounds session features in-depth case studies to encourage retention of the lessons and provide new perspectives on the management of patients during the COVID-19 pandemic. This program will focus on optimizing outcomes for hospitalized and nonhospitalized patients with COVID-19 through the use of novel agents authorized for emergency use.

This activity will cover the treatment and management of patients locally-advanced or metastatic urothelial carcinoma.

This program targets healthcare gaps related to the treatment and management of atrial fibrillation (AF), impacting outcomes through guidelines and best practices, appropriate antiarrhythmic use and shared decision-making.

This live activity will cover early detection and intervention in cancer.